Exicure Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Exicure.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 24.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Little Excitement Around Exicure, Inc.'s (NASDAQ:XCUR) Revenues As Shares Take 25% Pounding
Aug 29
Exicure to get $5.4M equity financing, reduce workforce & end R&D, preclinical activities
Sep 26Exicure Q2 GAAP loss per share narrows, revenue up
Aug 15Exicure regains compliance with Nasdaq's minimum bid price requirement
Jul 20Exicure slides 31% as it implements reverse-stock-split to get back Nasdaq compliance
Jun 29Does Exicure (NASDAQ:XCUR) Have A Healthy Balance Sheet?
Aug 25Does Exicure (NASDAQ:XCUR) Have A Healthy Balance Sheet?
Mar 10A Look At Exicure's (NASDAQ:XCUR) Share Price Returns
Jan 13Exicure announces issuance of two new U.S. patents, and new patent allowance
Dec 21How Much Of Exicure, Inc. (NASDAQ:XCUR) Do Institutions Own?
Dec 15Exicure (XCUR) Investor Presentation - Slideshow
Nov 18In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Exicure has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2023 | 24 | 3 | -22 | -22 | N/A |
| 3/31/2023 | 26 | 1 | -26 | -26 | N/A |
| 12/31/2022 | 29 | -3 | -36 | -36 | N/A |
| 9/30/2022 | 9 | -35 | -43 | -42 | N/A |
| 6/30/2022 | 3 | -53 | -31 | -31 | N/A |
| 3/31/2022 | 1 | -60 | -34 | -33 | N/A |
| 12/31/2021 | 0 | -64 | -36 | -35 | N/A |
| 9/30/2021 | -2 | -63 | -34 | -33 | N/A |
| 6/30/2021 | 4 | -48 | -47 | -46 | N/A |
| 3/31/2021 | 8 | -38 | -49 | -46 | N/A |
| 12/31/2020 | 17 | -25 | -42 | -39 | N/A |
| 9/30/2020 | 17 | -22 | -16 | -12 | N/A |
| 6/30/2020 | 15 | -19 | -13 | -9 | N/A |
| 3/31/2020 | 10 | -20 | -4 | -3 | N/A |
| 12/31/2019 | 1 | -26 | 0 | 1 | N/A |
| 9/30/2019 | 1 | -21 | -20 | -20 | N/A |
| 6/30/2019 | 1 | -21 | -19 | -19 | N/A |
| 3/31/2019 | 0 | -22 | -19 | -19 | N/A |
| 12/31/2018 | 0 | -22 | -20 | -19 | N/A |
| 9/30/2018 | 2 | -21 | -19 | -19 | N/A |
| 6/30/2018 | 5 | -18 | -19 | -19 | N/A |
| 3/31/2018 | 7 | -14 | -18 | -17 | N/A |
| 12/31/2017 | 10 | -11 | -21 | -20 | N/A |
| 9/30/2017 | 8 | -13 | -10 | -9 | N/A |
| 6/30/2017 | 6 | -15 | -9 | -8 | N/A |
| 3/31/2017 | 3 | -16 | N/A | -8 | N/A |
| 12/31/2016 | 1 | -17 | N/A | -5 | N/A |
| 12/31/2015 | 2 | -6 | N/A | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if XCUR's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if XCUR's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if XCUR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if XCUR's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if XCUR's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XCUR's Return on Equity is forecast to be high in 3 years time